Cimetropium Bromide

西托溴铵

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCimetropium Bromide
Drug Alias Namecimetropii bromidumAlginorDA-3177
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsGastrointestinal Diseases
Global Approved IndicationsGastrointestinal Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryItaly
Original Approved Date1984/01/01
Country/TerritoryItaly
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsGastrointestinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeA03BB05
Related LinksWikipediaKEGG